The products were also marketed as being helpful in “amino acid therapy” to treat Parkinson’s disease, Alzheimer’s disorder, melancholy, obsessive compulsive sickness, consideration deficit hyperactivity ailment, fibromyalgia, and different situations, based on a September 2010 review of case look at solution two businesses’ internet sites, case study answer FDA said in a press release. The FDA warned case examine solution two companies to prevent making unapproved drug claims about case examine solution supplements, which case look at solution corporations did not do. A follow up review of case look at solution agencies’ internet sites in February 2011 discovered continual unverified medical claims approximately case study answer offending items. The injunction, filed on Sept. 13, prohibits case examine answer distribution of case look at answer amino acid products unless case study solution product claims are removed from case study answer agencies’ websites and their removing is reviewed and cleared by an impartial investigator. Should case study solution subsidiaries fail to comply, case study answer FDA can order case look at answer companies to prevent all distribution of case examine answer advertised items.
The products were also marketed as being helpful in “amino acid therapy” to treat Parkinson’s disease, Alzheimer’s disorder, melancholy, obsessive compulsive sickness, consideration deficit hyperactivity ailment, fibromyalgia, and different situations, based on a September 2010 review of case look at solution two businesses’ internet sites, case study answer FDA said in a press release. The FDA warned case examine solution two companies to prevent making unapproved drug claims about case examine solution supplements, which case look at solution corporations did not do. A follow up review of case look at solution agencies’ internet sites in February 2011 discovered continual unverified medical claims approximately case study answer offending items. The injunction, filed on Sept. 13, prohibits case examine answer distribution of case look at answer amino acid products unless case study solution product claims are removed from case study answer agencies’ websites and their removing is reviewed and cleared by an impartial investigator. Should case study solution subsidiaries fail to comply, case study answer FDA can order case look at answer companies to prevent all distribution of case examine answer advertised items.